3 Stocks Pushing The Drugs Industry Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Drugs industry as a whole closed the day down 0.5% versus the S&P 500, which was unchanged. Laggards within the Drugs industry included Natural Alternatives International ( NAII), down 1.8%, Reliv' International ( RELV), down 6.1%, EntreMed ( ENMD), down 4.2%, ProPhase Labs ( PRPH), down 5.4% and Celator Pharmaceuticals ( CPXX), down 4.2%.

TheStreet Ratings Group would like to highlight 3 stocks that pushed the industry lower today:

Celator Pharmaceuticals ( CPXX) is one of the companies that pushed the Drugs industry lower today. Celator Pharmaceuticals was down $0.11 (4.2%) to $2.49 on light volume. Throughout the day, 6,670 shares of Celator Pharmaceuticals exchanged hands as compared to its average daily volume of 27,000 shares. The stock ranged in price between $2.47-$2.63 after having opened the day at $2.63 as compared to the previous trading day's close of $2.60.

Celator Pharmaceuticals has a market cap of $69.1 million and is part of the health care sector. Shares are down 20.0% year-to-date as of the close of trading on Monday. Currently there is 1 analyst who rates Celator Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

What Does a Winner Look Like?

Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here

Ardelyx Has Big Potential

Ardelyx Has Big Potential

'Mad Money' Lightning Round: Be Careful With Fitbit

Jim Cramer's 'Mad Money' Recap: Here's Why It's Time to Start Buying Stocks